lovastatin has been researched along with Dengue in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behnam, MA; Boldescu, V; Klein, CD; Nitsche, C | 1 |
| Castellanos, JE; Correa-Londoño, LA; Gallego-Gómez, JC; Martinez-Gutierrez, M; Osorio, JE | 1 |
| Cam Huong, NT; Farrar, J; Hang, NT; Hue Tai, LT; Khanh, LP; Kien, DTH; Nguyen, CVV; Nhon, VT; Quyen, NTH; Simmons, CP; Tran, NTT; Truong, NT; Van Tram, T; Whitehorn, J; Wills, B; Wolbers, M | 1 |
| Harris, E; Peña, J | 1 |
| Dung, NT; Farrar, J; Hien, TT; Merson, L; Peeling, R; Simmons, C; Tai, LT; Truong, NT; Van Hao, N; Van Vinh Chau, N; Whitehorn, J; Wills, B; Wolbers, M | 1 |
1 review(s) available for lovastatin and Dengue
| Article | Year |
|---|---|
The Medicinal Chemistry of Dengue Virus.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; Dengue; Dengue Virus; Humans; Molecular Conformation; Structure-Activity Relationship | 2016 |
2 trial(s) available for lovastatin and Dengue
| Article | Year |
|---|---|
Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Adult; Anti-Inflammatory Agents; Dengue; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lovastatin; Male; Placebos; Treatment Outcome; Vietnam; Young Adult | 2016 |
Lovastatin for adult patients with dengue: protocol for a randomised controlled trial.
Topics: Dengue; Double-Blind Method; England; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Research Design; Sample Size; Time Factors; Treatment Outcome; Vietnam | 2012 |
2 other study(ies) available for lovastatin and Dengue
| Article | Year |
|---|---|
Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2.
Topics: Analysis of Variance; Animals; Dengue; Dengue Virus; Dose-Response Relationship, Drug; Kaplan-Meier Estimate; Lovastatin; Mice; Mice, Mutant Strains; Treatment Outcome; Viremia; Virus Assembly | 2014 |
Early dengue virus protein synthesis induces extensive rearrangement of the endoplasmic reticulum independent of the UPR and SREBP-2 pathway.
Topics: Absorption; Activating Transcription Factor 6; Animals; Cell Line, Tumor; Dengue; Dengue Virus; DNA-Binding Proteins; Endoplasmic Reticulum; Humans; Lipids; Lovastatin; Mice; Protein Biosynthesis; Regulatory Factor X Transcription Factors; Signal Transduction; Sterol Regulatory Element Binding Protein 2; Transcription Factors; Unfolded Protein Response; Up-Regulation; Virion; X-Box Binding Protein 1 | 2012 |